Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2016-06-06 Director's Dealing
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding - Replacement
Director's Dealing Classification · 99% confidence The document is identified by the 'RNS Number' header and contains specific details about a transaction involving a director ('Tony Rice, Non-Executive Director, purchased 20,000 ordinary shares'). This directly corresponds to the definition of Director's Dealing (insider trades). The filing code for this activity is DIRS. Although it is distributed via RNS, the content is specific enough to warrant the DIRS classification over the general RNS fallback.
2016-06-06 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is identified by the RNS Number (3271A) and explicitly states it is providing information via RNS, the company news service from the London Stock Exchange. The content details a transaction where a Non-Executive Director (Tony Rice) purchased ordinary shares in the Company. This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). Therefore, the most specific classification is DIRS.
2016-06-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document explicitly starts with 'RNS Number : 3839Y' and contains the header 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES'. This structure, along with the content detailing changes in voting rights percentages (crossing the 3% threshold) held by Kames Capital Plc in Dechra Pharmaceuticals PLC, clearly identifies it as a regulatory filing concerning a major shareholder notification. This aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2016-05-16 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is very short (1902 characters) and begins with an 'RNS Number'. It explicitly states, 'In conformity with DTR 5.6.1R, the Company notifies the market of the following:' and proceeds to announce the total number of shares with voting rights (92,718,138). This type of notification regarding the total voting rights denominator, often required under Disclosure and Transparency Rules (DTR), is a standard regulatory announcement. While it relates to share capital, it is not a formal share issue (SHA) or a transaction in own shares (POS), but rather a mandatory periodic disclosure of the total share count. Given the structure (RNS Number, notification format) and the content (total voting rights), it fits best under the general regulatory announcement category, RNS, as it is a specific regulatory disclosure that doesn't map perfectly to the other detailed categories like DIV, ER, or 10-K.
2016-04-29 English
Completion of Acquisition of Putney
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces the 'Completion of Acquisition of Putney, Inc.' and mentions future integration details will be provided in a trading update. This is a general regulatory announcement concerning a significant corporate action (M&A completion) that is not a full report (like 10-K or IR) or a specific filing like Director's Dealing or Dividend Notice. Since it is a general regulatory announcement distributed via the RNS system and doesn't fit perfectly into the M&A Activity (TAR) category (which usually covers the proposal/bid phase, though completion is related), the most appropriate general category for miscellaneous regulatory news distributed via RNS is 'Regulatory Filings' (RNS), as per the definition and the source identifier.
2016-04-22 English
Update on Proposed Acquisition of Putney, Inc.
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 3907V' header, indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses an 'Update on Proposed Acquisition of Putney, Inc.' and mentions the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. This is a specific corporate action update related to a potential merger or acquisition activity. While it relates to M&A (TAR), the primary nature of this short announcement, distributed via RNS, is a general regulatory update that doesn't fit perfectly into the specific M&A document types (like a formal offer document). Given the explicit RNS identification and the nature of providing a brief update on a regulatory hurdle being cleared for a transaction, the most appropriate general classification for a non-standard, time-sensitive regulatory disclosure is RNS, especially since the document ends by stating 'This information is provided by RNS'. However, since the core subject is a merger/acquisition update, TAR (M&A Activity) is also highly relevant. Given the structure and the explicit RNS source tag, RNS is the safest fallback for a general regulatory news wire update. If the document were longer and contained the full details of the merger agreement, TAR would be better. Since it's a brief update distributed via the RNS system, RNS is chosen as the primary classification.
2016-04-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.